CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rafa Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rafa Laboratories Ltd
Phone: +972 25893939p:+972 25893939 JERUSALEM, 97770  Israel Ticker: RAFARAFA
Business Summary
Rafa Laboratories Ltd. is an Israel-based company that develops, manufactures, and markets pharmaceutical products. The Company focuses on a range of therapeutic areas, including oncology, analgesia, diagnostics, and specialty medicines. Its activities cover drug development, production of active pharmaceutical ingredients, and distribution of finished dosage forms. Rafa Laboratories Ltd. provides both branded and generic products, as well as hospital-oriented solutions and over-the-counter medicines. The Company also offers contract manufacturing and research services. It operates through collaborations with local and international partners and supplies its products to domestic and various global markets.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202612/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer AmirLevin
Chief Financial Officer BenBliti
Vice President of Sales OvadiaIs gone
Vice President of Marketing RachelSamuel
Vice President - Business Development MoodyTeicher

General Information
Number of Employees: 261 (As of 12/31/2025)
Outstanding Shares: 97,977,944 (As of 6/30/2026)
Stock Exchange: TLV
Fax Number: +972 25870282


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, November 1, 2026